<DOC>
	<DOCNO>NCT00006048</DOCNO>
	<brief_summary>RATIONALE : Some tumor need growth factor produce body 's white blood cell keep grow . ZD 1839 may interfere growth factor stop tumor grow . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know whether chemotherapy effective without ZD 1839 non-small cell lung cancer . PURPOSE : Randomized phase III trial compare effectiveness combination chemotherapy without ZD 1839 treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>ZD 1839 Plus Combination Chemotherapy Treating Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare 1 year survival rate , time worsen disease relate symptom , progression free survival chemotherapy naive patient stage IIIB IV non-small cell lung cancer treat one two dos ZD 1839 placebo combine gemcitabine cisplatin . OUTLINE : This randomize , double blind , placebo control , multicenter study . Patients randomize one three treatment arm . Patients receive gemcitabine cisplatin combine low dose oral ZD 1839 ( arm I ) , high dose oral ZD 1839 ( arm II ) , placebo ( arm III ) . PROJECTED ACCRUAL : A total 1,029 patient ( 343 per arm ) accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove nonsmall cell lung cancer Stage III disease curable surgery radiotherapy OR Stage IV disease Chemotherapy naive PATIENT CHARACTERISTICS : Age : 18 Performance status : 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 2,000/mm3 WBC least 4,000/mm3 Hepatic : ALT AST less 2.5 time upper limit normal ( ULN ) ( less 5 time ULN liver metastasis present ) Bilirubin le 1.25 time ULN Renal : Creatinine le 1.5 time ULN Creatinine clearance great 60 mL/min Cardiovascular : No evidence severe uncontrolled cardiovascular disease Pulmonary : No evidence severe uncontrolled pulmonary disease PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : No concurrent systemic endocrine therapy know effect nonsmall cell lung cancer Radiotherapy : See Disease Characteristics Prior localize irradiation allow Surgery : See Disease Characteristics Prior surgery allow Other : No concurrent drug know significant cytochrome P450 3A4 inhibitory effect ( e.g. , ketoconazole , itraconazole , troleandomycin , erythromycin , diltiazem , verapamil )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2001</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>